DGTR Initiates Anti-dumping Investigation on Bromo OTBN (Anti Blood Pressure Chemical) from China on Neogen Chemicals with Two More Producers Support

· Bromo-OTBN, or 4-Bromomethyl-2-cyanobiphenyl, is a crucial chemical intermediate used primarily in the pharmaceutical industry, particularly in the synthesis of angiotensin II receptor antagonists (also known as sartans). These drugs are vital for treating high blood pressure (hypertension) and heart failure. Bromo-OTBN's reactivity and availability also make it useful in other areas of organic synthesis.

· The product under consideration in the present case is “4-(Bromomethyl)-2’- cyanobiphenyl” (hereinafter also referred to as “Product under Consideration” or PUC. As per the information contained in the Application filed by the domestic industry, the PUC is also known as “Bromo OTBN”. Bromo OTBN is a cream / off white colored powder used in the manufacturing of certain pharmaceutical API’s, mainly Valsartan, Irbesartan & Telmisartan.

[DGTR Initiation Notification (Case No. AD(OI) – 20/2025) dated 30 June, 2025]